Cargando…
wEight chanGes, caRdio-mEtabolic risks and morTality in patients with hyperthyroidism (EGRET): a protocol for a CPRD–HES linked cohort study
INTRODUCTION: Hyperthyroidism is a common condition affecting up to 3% of the UK population. Treatment improves symptoms and reduces the risk of atrial fibrillation and stroke that contribute to increased mortality. The most common symptom is weight loss, which is reversed during treatment. However,...
Autores principales: | Torlinska, Barbara, Hazlehurst, Jonathan M, Nirantharakumar, Krishnarajah, Thomas, G Neil, Priestley, Julia R, Finnikin, Samuel J, Saunders, Philip, Abrams, Keith R, Boelaert, Kristien |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8488707/ https://www.ncbi.nlm.nih.gov/pubmed/34598995 http://dx.doi.org/10.1136/bmjopen-2021-055219 |
Ejemplares similares
-
OR26-05 Long-term Mortality And Cardiometabolic Effects Of Treatment For Hyperthyroidism: EGRET Study
por: Torlinska, Barbara, et al.
Publicado: (2023) -
Study protocol for a randomized controlled trial: Qiliqiangxin in heart failUre: assESsment of reduction in morTality (QUEST)
por: Yao, Wenming, et al.
Publicado: (2020) -
Imblanzirea divinei egrete /
por: Pitol, Sergio, 1933-2018
Publicado: (2008) -
Completeness, agreement, and representativeness of ethnicity recording in the United Kingdom’s Clinical Practice Research Datalink (CPRD) and linked Hospital Episode Statistics (HES)
por: Shiekh, Suhail I., et al.
Publicado: (2023) -
Clinical Perspectives for (18)F-FDG PET Imaging in Pediatric Oncology: Μetabolic Tumor Volume and Radiomics
por: Lyra, Vassiliki, et al.
Publicado: (2022)